- Home
- CLPS vs PASG Comparison
CLPS vs PASG Comparison
Compare CLPS & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- PASG
- Stock Information
- Founded
- CLPS 2005
- PASG 2017
- Country
- CLPS Hong Kong
- PASG United States
- Employees
- CLPS N/A
- PASG N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- PASG Health Care
- Exchange
- CLPS Nasdaq
- PASG Nasdaq
- Market Cap
- CLPS 26.3M
- PASG 31.1M
- IPO Year
- CLPS 2018
- PASG 2020
- Fundamental
- Price
- CLPS $1.00
- PASG $0.39
- Analyst Decision
- CLPS
- PASG Strong Buy
- Analyst Count
- CLPS 0
- PASG 3
- Target Price
- CLPS N/A
- PASG $7.67
- AVG Volume (30 Days)
- CLPS 11.6K
- PASG 323.5K
- Earning Date
- CLPS 03-05-2025
- PASG 08-07-2025
- Dividend Yield
- CLPS 13.13%
- PASG N/A
- EPS Growth
- CLPS N/A
- PASG N/A
- EPS
- CLPS N/A
- PASG N/A
- Revenue
- CLPS $153,816,045.00
- PASG N/A
- Revenue This Year
- CLPS N/A
- PASG N/A
- Revenue Next Year
- CLPS N/A
- PASG N/A
- P/E Ratio
- CLPS N/A
- PASG N/A
- Revenue Growth
- CLPS 5.81
- PASG N/A
- 52 Week Low
- CLPS $0.68
- PASG $0.26
- 52 Week High
- CLPS $1.70
- PASG $1.33
- Technical
- Relative Strength Index (RSI)
- CLPS 53.85
- PASG 48.43
- Support Level
- CLPS $0.90
- PASG $0.38
- Resistance Level
- CLPS $1.08
- PASG $0.52
- Average True Range (ATR)
- CLPS 0.06
- PASG 0.04
- MACD
- CLPS 0.01
- PASG -0.01
- Stochastic Oscillator
- CLPS 55.56
- PASG 11.03
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.